Hemodynamic effects and power spectral analysis of heart rate and arterial pressure variabilities induced by lercanidipine and its enantiomers in conscious dogs

Journal of Cardiovascular Pharmacology

Volumn 29, Issue SUPPL. 1, 1997, Pages

  Testa, R ^b   Rimoldi, O ^a   Sironi, G ^b   Leonardi, A ^b   Malliani, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Recordati SpA   (Italy)

Author keywords

1,4 Dihydropyridine calcium; Lercanidipine; Lercanidipine enantiomers

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LERCANIDIPINE; PROPRANOLOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCULATION; CORONARY ARTERY DILATATION; DOG; DOSE RESPONSE; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; STATISTICAL ANALYSIS;

EID: 0031007176     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199729001-00011     Document Type: Article

References (19)

1. Triggle D, Swany V. Calcium antagonists: some chemical, pharmacological aspects. Circ Res 1983;52:117-28.
2. Kiowski W, Bolli P, Erne P, Buhler F. Mechanisms of action of calcium antagonists in hypertension. J Cardiovasc Pharmacol 1987;10(suppl 10):S23-8.
3. Eichelbaum M, Echiren M. Clinic pharmacology of calcium antagonists. A clinical review. J Cardiovasc Pharmacol 1984;6: S963-7.
4. Zanchetti A. Role of calcium antagonists in systemic hypertension. Am J Cardiol 1987;59:130B-6B.
5. Omtsuka M, Yokota M, Kodama I, Yamada K. New generation dihydropyridine calcium entry blockers in search of greater selectivity for one tissue subtype. Gen Pharmacol 1989;20:539-56.
6. Freedam D, Waters D. Second generation dihydropyridine calcium antagonists. Drugs 1987;34:578-99.
7. Guarneri L, Angelico P, Ibba M, et al. Pharmacological in vitro studies of the new 1,4-dihydropiridine calcium antagonist lercanidipine. Arzneimittelforschung 1996;46:15-24.
8. Bianchi G, Passoni A, Griffini PL. Effects of a new calcium antagonist, Rec 15/2375, on cardiac contractility of conscious rabbits. Pharmacol Res 1989;21:193-200.
9. Sironi G, Montagna E, Greto L, Leonardi A, Testa R. Hemodynamic effects of lercanidipine in anaesthetized open-chest dogs. Arzneimittelforschung 1996;46:256-61.
10. Sironi G, Montagna E, Greto L, Bianchi G, Leonardi A, Testa R. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs. Arzneimittelforschung 1996;46: 145-52.
11. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation. A quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-2.
12. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178-93.
13. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84:482-92.
14. Rimoldi O, Pierini S, Ferrari A, Cerutti S, Pagani M, Malliani A. Analysis of short-term oscillations of RR and arterial pressure in conscious dogs. Am J Physiol 1991;258:H967-76.
15. Pagani M, Pizzinelli P, Furlan R, Guzzetti S, Rimoldi O, Sandrone G. Effects of verapamil, nifedipine and dilazep on left ventricular relaxation in the conscious dogs. Cardiovasc Res 1987;21:55-64.
16. Karliner JS, LeWinter MM, Mahler F, Engler R, O'Rourke RA. Pharmacology and haemodynamic influences of the rate of the isovolumic left ventricular relaxation in the normal conscious dog. J Clin Invest 1977;60:511-21.
17. Frederiksen J W, Weiss JL, Weisfeldt ML. Time constant of isovolumic pressure fall: determinants in the working left ventricle. J Physiol 1978;235:H701-6.
18. Berger RD, Saul JP, Cohen RJ. Transfer function analysis of autonomie regulation. I. Canine atrial rate response. Am J Physiol 1989;256:H142-52.
19. Persson PB, Ehmke H, Koehler WW, Kirchheim HR. Identification of major slow blood pressure oscillations in conscious dogs. Am J Physiol 1990;259:H1050-5.